Company · CIK 0001789972
Cullinan Therapeutics, Inc.
CGEMSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$15.53+$0.07 (+0.453%)
CGEM · Last trade
- Prev close
- $15.46
- Range (29d)
- $14.53 – $21.67
On the record
Recent filings
- 8-KCGEMCurrent report0001193125-26-411011 · 195.1 KBSEC(opens sec.gov)
- 8-KCGEMCurrent report0001193125-26-400144 · 193.6 KBSEC(opens sec.gov)
- 8-KCGEMCurrent report0001193125-26-389844 · 242.0 KBSEC(opens sec.gov)
- 144CGEMCullinan Therapeutics, Inc.0001950047-26-009190 · 7.7 KBSEC(opens sec.gov)
- SCHEDULE 13G/ACGEMCullinan Therapeutics, Inc.0000921895-26-002166 · 25.9 KBSEC(opens sec.gov)
- SCHEDULE 13GCGEMCullinan Therapeutics, Inc.0000080255-26-000574 · 7.9 KBSEC(opens sec.gov)
- 144CGEMCullinan Therapeutics, Inc.0001950047-26-008087 · 5.8 KBSEC(opens sec.gov)
- 8-KCGEMCurrent report0001193125-26-347400 · 218.2 KBSEC(opens sec.gov)
- SCHEDULE 13GCGEMCullinan Therapeutics, Inc.0000093751-26-000446 · 8.4 KBSEC(opens sec.gov)
- 10-QCGEMQuarterly update0001193125-26-336717 · 8.2 MBSEC(opens sec.gov)
Insiders
- AHMED NADIMDirector, President and CEO
- Allen Andrew RDirector
- Baeuerle PatrickChief Scientific Officer
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- BVF GP HOLDINGS LLC10% Owner
- BVF I GP LLCSee Explanation of Responses
- BVF II GP LLCSee Explanation of Responses
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
Tickers
Addresses
business
ONE MAIN STREET SUITE 1350
CAMBRIDGE, MA, 02142
mailing
ONE MAIN STREET SUITE 1350
CAMBRIDGE, MA, 02142
Former names
- Cullinan Oncology, Inc.2024-04-02
- Cullinan Management, Inc.2021-02-22
- Cullinan Oncology, LLC2021-01-06
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies